About Aethlon Medical
Aethlon Medical is the developer of the Hemopurifier®, a first–in–class medical device to treat infectious disease. The Hemopurifier® addresses the largest opportunity in infectious disease, the treatment of drug and vaccine resistant viruses. Regulatory and commercialization initiatives in the United States are focused on bioterror threats, while international initiatives are directed towards naturally evolving pandemic threats, and chronic infectious disease conditions including Hepatitis–C (HCV) and the Human Immunodeficiency Virus (HIV).

The Technology
The Hemourifier® is a novel multi–patented platform technology designed for the single use removal of viral pathogens from blood. The cartridge mimics the natural response of clearing infectious viruses and related toxins prior to cell and organ infection, and is usable with portable pumps or within the established infrastructure of dialysis machines located in hospitals and in clinics. Invitro studies of the Hemopurifier® have documented efficiency in capturing a broad‐spectrum of viruses, including HIV, Hepatitis–C (HCV), Dengue, Ebola, Marburg, Lassa, and Pox viruses. A recent study at the Apollo Hospital in Delhi, India documented initial safety of the Hemopurifier®, and early efficacy observations during 24–treatments administered to four heath compromised dialysis patients co–infected with HCV. The Hemopurifier® is increasingly being covered by the science and news media, with recent stories in; Popular Science, Reader Digest, The Red Herring, Genetic Engineering News, The Scientist Magazine, The National Homeland Defense Journal, CNN, NBC, ABC, the BBC.